Skip to main content

Chest-Compression-Only CPR Shows Long-Term Survival Benefit


PARIS, France — The short-term mortality benefit of using chest compressions only rather than chest compressions plus rescue breathing in the resuscitation of patients with out-of-hospital cardiac arrest appears to be continued in the long term, a new study suggests [1].
The study, published online in Circulation on December 10, 2012, was conducted by a team led by Dr Florence Dumas(Descartes University, Paris, France).
They conclude: "The current results provide important evidence that chest-compression alone . . . can achieve better overall prognosis and should be considered the . . . approach for nearly all adult patients for whom dispatchers suspect cardiac arrest."
The researchers combined data from two randomized trials comparing chest compression alone or chest compression plus rescue breathing on short-term mortality and ascertained long-term vital status of patients from national and state death records.
Results showed that among the 2496 subjects there were 2260 deaths and 236 long-term survivors. Randomization to chest compression alone compared with chest compression plus rescue breathing was associated with a lower risk of death in the long term (one, three, and five years) after adjustment for potential confounders (adjusted HR=0.91; 95% CI 0.83–0.99).
"Meaningful Long-Term Public-Health Benefits"
The authors say that they had expected that the early survival difference may have been amplified after hospital discharge, but this was not seen. Rather, the long-term survival benefit of the chest-compressions-alone approach appeared to be attributable entirely to an early survival differential that persisted over subsequent years of follow-up, with the survival curves during long-term follow-up running parallel. But these results still suggest that short-term-outcome differences do translate to meaningful long-term public-health benefits, they add.
It has previously been suggested that chest compressions alone would be beneficial only for patients with collapse of cardiac origin and those with a shockable rhythm. Subgroup analysis of the current data, while not statistically definitive, supports this view, but there was no evidence of harm among those for whom oxygenation and ventilation might in theory be more important such as noncardiac etiology or unwitnessed arrest, the paper notes.
The authors add: "The results are specific to dispatcher-assisted layperson CPR, though they provide a useful context to consider layperson CPR training and guidelines."
Noting that laypersons are often especially challenged to perform effective rescue breathing even after training, they conclude that the current results "support the 2010 guidelines that prioritize chest compressions regardless of training status or dispatcher assistance."

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such
Post a Comment
Read more

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volume delivered to
Post a Comment
Read more

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n
4 comments
Read more